CAS No. |
2821770-49-2 |
中文名称 |
DL-01 |
英文名称 |
N-((11S,14S)-11-(4-(dipropylamino)butyl)-1-((S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-10H-[1,3]dioxolo[4,5-g]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-14-yl)-15-methyl-7,10,13-trioxo-4-oxa-6,9,12-triazahexadecan-14-yl)-6-(2-(methylsulfonyl)pyrimidin-5-yl)hex-5-ynamide |
别名 |
DL-01;Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]-;Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,;Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′ |
标准英文名 |
N-((11S,14S)-11-(4-(dipropylamino)butyl)-1-((S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-10H-[1,3]dioxolo[4,5-g]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-14-yl)-15-methyl-7,10,13-trioxo-4-oxa-6,9,12-triazahexadecan-14-yl)-6-(2-(methylsulfonyl)pyrimidin-5-yl)hex-5-ynamide |
分子式 |
C55H71N9O13S |
分子量 |
1098.29
|
精确分子量 |
1097.49
|
SMILES |
C(CCOCNC(CNC([C@@H](NC([C@@H](NC(CCCC#CC=1C=NC(S(C)(=O)=O)=NC1)=O)[C@H](C)C)=O)CCCCN(CCC)CCC)=O)=O)C2=C3C(C=4N(C3)C(=O)C5=C(C4)[C@](CC)(O)C(=O)OC5)=NC=6C2=CC7=C(C6)OCO7 |
标准SMILES |
CC(C)[C@H](NC(=O)CCCC#CC1=CN=C(N=C1)S(C)(=O)=O)C(=O)N[C@@H](CCCCN(CCC)CCC)C(=O)NCC(=O)NCOCCCC1=C2CN3C(=O)C4COC(=O)[C@](O)(CC)C=4C=C3C2=NC2=CC3OCOC=3C=C12 |
用途 |
DL-01 is an antibody-drug conjugate (ADC) payload-linker conjugate used for the synthesis of ADCs. |
InChIKey |
HZTIRNJXQJVRDP-OPQNLWLXSA-N |